Analysen von Dominic Lunn

02.02.23 Novartis Underperform Credit Suisse Group
06.01.23 Novartis Underperform Credit Suisse Group
26.10.22 Novartis Underperform Credit Suisse Group
23.09.22 Novartis Underperform Credit Suisse Group
15.09.22 Novartis Underperform Credit Suisse Group
28.07.22 GlaxoSmithKline Underperform Credit Suisse Group
20.07.22 GSK Underperform Credit Suisse Group
15.07.22 GSK Underperform Credit Suisse Group
28.04.22 GSK Underperform Credit Suisse Group
10.02.22 GSK Underperform Credit Suisse Group
29.07.21 GSK Underperform Credit Suisse Group
24.06.21 GSK verkaufen Credit Suisse Group